Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Lehigh Valley Hospital - Muhlenberg
2361
mi
from 91732
Bethlehem, PA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
2361
mi
from 91732
Bethlehem, PA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
2296
mi
from 91732
Danville, PA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
2296
mi
from 91732
Danville, PA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Group
2231
mi
from 91732
State College, PA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Group
2231
mi
from 91732
State College, PA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
AnMedical Health Cancer Center
2009
mi
from 91732
Anderson, SC
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
AnMedical Health Cancer Center
2009
mi
from 91732
Anderson, SC
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
AnMedical Health Hospital
2008
mi
from 91732
Anderson, SC
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
AnMedical Health Hospital
2008
mi
from 91732
Anderson, SC
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
2018
mi
from 91732
Greenville, SC
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
2018
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Rapid City Regional Hospital
1049
mi
from 91732
Rapid City, SD
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Rapid City Regional Hospital
1049
mi
from 91732
Rapid City, SD
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Avera Cancer Institute
1314
mi
from 91732
Sioux Falls, SD
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Avera Cancer Institute
1314
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Avera McKennan Hospital and University Health Center
1313
mi
from 91732
Sioux Falls, SD
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Avera McKennan Hospital and University Health Center
1313
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
1746
mi
from 91732
Green Bay, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology Limited at Saint Mary's Hospital
1746
mi
from 91732
Green Bay, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology at Saint Vincent Hospital
1746
mi
from 91732
Green Bay, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology at Saint Vincent Hospital
1746
mi
from 91732
Green Bay, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Holy Family Memorial Hospital
1756
mi
from 91732
Manitowoc, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Holy Family Memorial Hospital
1756
mi
from 91732
Manitowoc, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Bay Area Medical Center
1774
mi
from 91732
Marinette, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Bay Area Medical Center
1774
mi
from 91732
Marinette, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Oconto Falls
1745
mi
from 91732
Oconto Falls, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Oconto Falls
1745
mi
from 91732
Oconto Falls, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Green Bay Oncology - Sturgeon Bay
1781
mi
from 91732
Sturgeon Bay, WI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Green Bay Oncology - Sturgeon Bay
1781
mi
from 91732
Sturgeon Bay, WI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
2496
mi
from 91732
Hartford, CT
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
2496
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Cancer Care Center-Boise
664
mi
from 91732
Boise, ID
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
664
mi
from 91732
Boise, ID
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Medical Center
1649
mi
from 91732
Bloomington, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Medical Center
1649
mi
from 91732
Bloomington, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Heartland Cancer Research NCORP
1645
mi
from 91732
Decatur, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Heartland Cancer Research NCORP
1645
mi
from 91732
Decatur, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Galesburg
1580
mi
from 91732
Galesburg, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Galesburg
1580
mi
from 91732
Galesburg, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Community Cancer Center Foundation
1647
mi
from 91732
Normal, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Community Cancer Center Foundation
1647
mi
from 91732
Normal, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Ottawa Regional Hospital and Healthcare Center
1662
mi
from 91732
Ottawa, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Ottawa Regional Hospital and Healthcare Center
1662
mi
from 91732
Ottawa, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
1614
mi
from 91732
Pekin, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
1614
mi
from 91732
Pekin, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
OSF Saint Francis Medical Center
1617
mi
from 91732
Peoria, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
OSF Saint Francis Medical Center
1617
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois Valley Hospital
1648
mi
from 91732
Peru, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois Valley Hospital
1648
mi
from 91732
Peru, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Carle Cancer Center
1685
mi
from 91732
Urbana, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Carle Cancer Center
1685
mi
from 91732
Urbana, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Carle Foundation Hospital
1685
mi
from 91732
Urbana, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Carle Foundation Hospital
1685
mi
from 91732
Urbana, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Franciscan Saint Anthony Health-Michigan City
1765
mi
from 91732
Michigan City, IN
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Franciscan Saint Anthony Health-Michigan City
1765
mi
from 91732
Michigan City, IN
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
McFarland Clinic PC-William R Bliss Cancer Center
1429
mi
from 91732
Ames, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
McFarland Clinic PC-William R Bliss Cancer Center
1429
mi
from 91732
Ames, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital
1527
mi
from 91732
Cedar Rapids, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
1527
mi
from 91732
Cedar Rapids, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Oncology Associates at Mercy Medical Center
1526
mi
from 91732
Cedar Rapids, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Oncology Associates at Mercy Medical Center
1526
mi
from 91732
Cedar Rapids, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
1415
mi
from 91732
Clive, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-West Des Moines
1415
mi
from 91732
Clive, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Iowa-Wide Oncology Research Coalition NCORP
1422
mi
from 91732
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Iowa-Wide Oncology Research Coalition NCORP
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Des Moines
1422
mi
from 91732
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Des Moines
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Laurel
1422
mi
from 91732
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Siouxland Regional Cancer Center
1303
mi
from 91732
Sioux City, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Siouxland Regional Cancer Center
1303
mi
from 91732
Sioux City, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Luke's Regional Medical Center
1304
mi
from 91732
Sioux City, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Luke's Regional Medical Center
1304
mi
from 91732
Sioux City, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Southwest Medical Center
980
mi
from 91732
Liberal, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Southwest Medical Center
980
mi
from 91732
Liberal, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Liberal
979
mi
from 91732
Liberal, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Liberal
979
mi
from 91732
Liberal, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Wichita
1182
mi
from 91732
Wichita, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wichita
1182
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Wichita NCI Community Oncology Research Program
1182
mi
from 91732
Wichita, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Wichita NCI Community Oncology Research Program
1182
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Michigan Cancer Research Consortium NCORP
1931
mi
from 91732
Ann Arbor, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Michigan Cancer Research Consortium NCORP
1931
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Mercy Hospital
1937
mi
from 91732
Ann Arbor, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Hospital
1937
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Spectrum Health Big Rapids Hospital
1857
mi
from 91732
Big Rapids, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Spectrum Health Big Rapids Hospital
1857
mi
from 91732
Big Rapids, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Beaumont Hospital-Dearborn
1956
mi
from 91732
Dearborn, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Beaumont Hospital-Dearborn
1956
mi
from 91732
Dearborn, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Genesys Regional Medical Center-West Flint Campus
1940
mi
from 91732
Flint, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Genesys Regional Medical Center-West Flint Campus
1940
mi
from 91732
Flint, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Research Consortium of West Michigan NCORP
1840
mi
from 91732
Grand Rapids, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Research Consortium of West Michigan NCORP
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Health Saint Mary's
1840
mi
from 91732
Grand Rapids, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Health Saint Mary's
1840
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Mary Mercy Hospital
1950
mi
from 91732
Livonia, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Mary Mercy Hospital
1950
mi
from 91732
Livonia, MI
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Health Mercy Campus
1813
mi
from 91732
Muskegon, MI
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Health Mercy Campus
1813
mi
from 91732
Muskegon, MI
Click here to add this to my saved trials